- TypeConference
- Location Barcelona, Cataluna, Spain
- Date 31-03-2020 - 02-04-2020
Medical/Healthcare/Hospital
Medicine has evolved. Market access must do the same.
Regulators, payers and HTAs are changing. Clear themes are emerging, including harmonisation, increasingly bespoke agreements and the consideration of new forms of evidence. But these are not solutions - health systems remain close to breaking point, with industry and payers often failing to reach agreement on value and affordability.
We must now harness maturing RWE and digital capabilities to advance access approaches and create a more affordable, value-driven system.
eyeforpharma Barcelona is the only event that brings together market access executives, key market access authorities and pharma leadership from across the commercial and clinical spectrum to accelerate harmonisation and spark our next evolutionary leap forward.
URL: Brochure: https://go.evvnt.com/547459-3?pid=6581 Speakers: Martin Price VP, Health Economics, Market Access and Reimbursement, EMEA Janssen, Tamir Singer Head of Commercial Access and Value, Commercial Medicines Directorate NHS England, Anna Papin di Pompeo Vice President, Government Affairs - Europe Merck Group, Giuseppe Rosano Member CVWP EMA and more. Time: 08:30 - 15:00